Pretransplant serum hepatitis C virus RNA levels predict response to antiviral treatment after living donor liver transplantation.
<h4>Background</h4>Given the limited efficacy and high adverse event rate associated with treatment of recurrent hepatitis C after liver transplantation, an individualized treatment strategy should be considered. The aim of this study was to identify predictors of response to antiviral t...
Main Authors: | Yoshihide Ueda, Toshimi Kaido, Yasuhiro Ogura, Kohei Ogawa, Atsushi Yoshizawa, Koichiro Hata, Yasuhiro Fujimoto, Aya Miyagawa-Hayashino, Hironori Haga, Hiroyuki Marusawa, Satoshi Teramukai, Shinji Uemoto, Tsutomu Chiba |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23505497/?tool=EBI |
Similar Items
-
Correction: Pretransplant Serum Hepatitis C Virus RNA Levels Predict Response to Antiviral Treatment after Living Donor Liver Transplantation
by: Yoshihide Ueda, et al.
Published: (2013-01-01) -
Correction: Pretransplant Serum Hepatitis C Virus RNA Levels Predict Response to Antiviral Treatment after Living Donor Liver Transplantation.
by: Yoshihide Ueda, et al.
Published: (2013-01-01) -
Significance of Semiquantitative Assessment of Preformed Donor-Specific Antibody Using Luminex Single Bead Assay in Living Related Liver Transplantation
by: Atsushi Yoshizawa, et al.
Published: (2013-01-01) -
Changes in Surgical Site Infections after Living Donor Liver Transplantation.
by: Masaki Yamamoto, et al.
Published: (2015-01-01) -
Urinary neutrophil gelatinase-associated lipocalin: a useful biomarker for tacrolimus-induced acute kidney injury in liver transplant patients.
by: Ayami Tsuchimoto, et al.
Published: (2014-01-01)